MS in Clinical & Experimental Therapeutics

*Application Deadline Extension For Fall 2020 Admission - June 1, 2020*

Overview

The USC School of Pharmacy Master’s program in Clinical and Experimental Therapeutics (CXPT) prepares students with foundational coursework in translational sciences, pharmacology, and clinical development to facilitate their performance at high-level basic, translational, and applied research in the discipline-specific to the graduate’s area of emphasis.

This may include a combination of drug screening, preclinical development, ADME (e.g. absorption, distribution, metabolism, elimination) and safety evaluation, and clinical testing.

Students will be given a wide spectrum of basic science and translational science training that will allow them to engage in drug development, optimized combination therapy, and individualize therapeutics (e.g. pharmacogenomics, infectious diseases, and metabolomics).

This foundational training will enable the graduates to be highly competitive for Ph.D. programs in pharmacology and related disciplines or employed in the pharmaceutical or biotech industry, or government (e.g. FDA, NIH).

Who should consider the Master’s program?

• Clinicians who would like further training in bench work in the context of clinical care of patients, including PharmD students, residents and fellows.
• Bench scientists who are interested in pursuing careers requiring further training in clinical disease and therapeutic areas.
• Individuals with a bachelor's degree in biology, chemistry, biochemistry, bioengineering, or pharmaceutical sciences with an interest in advancing their career options in the pharmaceutical.

For more information, please contact graduate admissions at pharmgrd@usc.edu